| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |